Usability and Acceptability Study of the P-STEP Mobile Application
| 対象疾患 | Asthma, Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Coronary Heart Disease |
|---|---|
| 相 | 該当なし |
| スポンサー | University of Leicester |
| ステータス | 完了 |
| 参加者数 | 178 名 |
| 介入（薬剤） | P-STEP Mobile Application |
| 開始日 | 2023年8月23日 |
| 完了日 | 2024年2月1日 |
| 結果公開日 | 2026年5月1日 |
概要
Assess the usability and acceptance of the P-STEP app, through allowing participants with specific chronic conditions to pilot the app for 12-weeks.
System Usability Scale
| 6-weeks | 57.92 ± 20.12 score on a scale |
|---|---|
| 12-week | 61.68 ± 22.09 score on a scale |
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and — University of Tennessee Graduate School of Medicine
- Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster — Chiesi Farmaceutici S.p.A.
- Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®T — Chiesi Farmaceutici S.p.A.
- Tiotropium/Salmeterol Inhalation Powder in COPD — Boehringer Ingelheim
- Risk Factors, Costs, and Impacts of ED Boarding — University of Maryland, Baltimore
- Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructiv — United Therapeutics